Covid-19 patients who were given the low-cost antidepressant fluvoxamine were significantly less likely to require hospitalization compared with those who weren’t, according to a new study
Patients who received the low-cost and widely available fluvoxamine were far less likely to be hospitalized in a clinical trial
Doctors are increasingly turning to monoclonal-antibody drugs to treat high-risk patients who get sick with Covid-19. WSJ takes a look at how the therapies work and why they’re important for saving lives. Illustration: Jacob Reynolds/WSJ
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Cheap, generic antidepressant shows promise in treating early COVID-19A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing drugs that could be...
Consulte Mais informação »
Covid-19: Record case rates in Wales and long Covid study begins in ScotlandFive things you need to know about the coronavirus pandemic this Tuesday evening.
Consulte Mais informação »
Covid-19 vaccine rates for kids echo regional disparities, worrying doctorsWhether children receive a dose of a Covid-19 vaccine often depends on where they call home.
Consulte Mais informação »
How COVID-19 in kids compares to the flu, other viruses in childrenCOVID-19 isn’t the only viral disease children are catching this year. Influenza, which sends thousands of children to the hospital each season, is predicted to ramp up in the coming months.
Consulte Mais informação »
CDC Extends COVID-19 Rules For Cruises Through Mid-JanuaryThe health and safety protocols put in place due to the coronavirus pandemic will then become voluntary, the agency said.
Consulte Mais informação »
COVID-19 live updates: FDA panel hours away from vote on Pfizer vaccine for kidsAn independent FDA advisory panel will debate and vote on whether to authorize the Pfizer vaccine for children ages 5 to 11. The nonbinding vote is expected between 4:30 p.m. and 5 p.m. ET today.
Consulte Mais informação »